The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 13, 2007

Filed:

May. 28, 2003
Applicants:

Robert J. Ternansky, San Diego, CA (US);

Andrew Mazar, San Diego, CA (US);

Patricia L. Gladstone, San Diego, CA (US);

Dimitri Coucouvanis, Ann Arbor, MI (US);

Amy L. Allan, Encinitas, CA (US);

Sean M. O'hare, San Diego, CA (US);

Melissa L. P. Price, Cardiff, CA (US);

Steven Robert Pirie-shepherd, Cardiff, CA (US);

Fernando Donate, San Diego, CA (US);

Inventors:

Robert J. Ternansky, San Diego, CA (US);

Andrew Mazar, San Diego, CA (US);

Patricia L. Gladstone, San Diego, CA (US);

Dimitri Coucouvanis, Ann Arbor, MI (US);

Amy L. Allan, Encinitas, CA (US);

Sean M. O'Hare, San Diego, CA (US);

Melissa L. P. Price, Cardiff, CA (US);

Steven Robert Pirie-Shepherd, Cardiff, CA (US);

Fernando Donate, San Diego, CA (US);

Assignees:

Attenuon, LLC, San Diego, CA (US);

Regents of the University of Michigan, Ann Arbor, MI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 11/00 (2006.01); A61K 31/28 (2006.01); A61K 31/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

The current invention provides novel thiomolybdate derivatives, methods of making novel thiomolybdate derivatives, pharmaceutical compositions of novel thiomolybdate derivatives, methods of using novel thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-κB dysregulation and methods of using pharmaceutical compositions of thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-κB dysregulation.


Find Patent Forward Citations

Loading…